Ly2334737
Title | Journal |
---|---|
Phase I study of Oral gemcitabine prodrug (LY2334737) alone and in combination with erlotinib in patients with advanced solid tumors. | Clinical cancer research : an official journal of the American Association for Cancer Research 20110915 |
Synthesis, crystallization, and biological evaluation of an orally active prodrug of gemcitabine. | Journal of medicinal chemistry 20091126 |